•
Sep 30, 2019

Lexicon Pharmaceuticals Q3 2019 Earnings Report

Total Revenue
$294M
Previous year: $6.86M
+4194.7%
EPS
-$0.1
Previous year: -$0.26
-61.5%
Research and development expenses
$26.7M
Selling, general and admin expenses
$13.9M
Gross Profit
$294M
Previous year: $6.31M
+4560.9%
Cash and Equivalents
$170M
Previous year: $48.9M
+248.0%
Free Cash Flow
$191M
Previous year: -$22.2M
-959.6%
Total Assets
$445M
Previous year: $310M
+43.3%

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals